Patents by Inventor Annabell Leske

Annabell Leske has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200069729
    Abstract: The present invention relates generally to new chemical combinations and methods for their use in the treatment of proliferative diseases and in particular cancer.
    Type: Application
    Filed: November 9, 2019
    Publication date: March 5, 2020
    Inventors: Gabriel Kremmidiotis, Annabell Leske, Tina Lavranos
  • Publication number: 20180289739
    Abstract: The present invention relates generally to new chemical combinations and methods for their use in the treatment of proliferative diseases and in particular cancer.
    Type: Application
    Filed: February 20, 2018
    Publication date: October 11, 2018
    Inventors: Gabriel Kremmidiotis, Annabell Leske, Tina Lavranos
  • Patent number: 9006284
    Abstract: A pharmaceutical composition of a tubulin polymerisation inhibitor and an mTOR inhibitor and a method of treating proliferative disease with a combination of a tubulin polymerisation inhibitor and an mTOR inhibitor.
    Type: Grant
    Filed: August 25, 2010
    Date of Patent: April 14, 2015
    Assignee: Bionomics Limited
    Inventors: Gabriel Kremmidiotis, David Bibby, Annabell Leske
  • Publication number: 20140248375
    Abstract: The present invention relates generally to new chemical combinations and methods for their use in the treatment of proliferative diseases and in particular cancer.
    Type: Application
    Filed: May 16, 2014
    Publication date: September 4, 2014
    Applicant: BIONOMICS LIMITED
    Inventors: Gabriel Kremmidiotis, Annabell Leske, Tina Lavranos
  • Publication number: 20120149665
    Abstract: A pharmaceutical composition of a tubulin polymerisation inhibitor and an mTOR inhibitor and a method of treating proliferative disease with a combination of a tubulin polymerisation inhibitor and an mTOR inhibitor.
    Type: Application
    Filed: August 25, 2010
    Publication date: June 14, 2012
    Applicant: Bionomics Limited
    Inventors: Gabriel Kremmidiotis, David Bibby, Annabell Leske
  • Publication number: 20110130367
    Abstract: The present invention relates generally to new chemical combinations and methods for their use in the treatment of proliferative diseases and in particular cancer.
    Type: Application
    Filed: November 24, 2010
    Publication date: June 2, 2011
    Applicant: BIONOMICS LIMITED
    Inventors: Gabriel Kremmidiotis, Annabell Leske, Tina Lavranos